中国临床药学杂志

参考文献

[1]江其生,王升启.基因治疗高血压的研究进展[J].国外医学.药学分册,2003,30(2):83.

[2]高平进,朱鼎良.原发性高血压的基因治疗[J].基础医学与临床,2002,22(6):494.

[3]Eric D,Hideaki Y,Chao JL,et al.Adenovirus-mediated kallikreingene delivery hypertension and protects against renal injury in deoxy-coritcosterone-salt rats[J].Immunopharmacology,1999,44(1-2):57.

[4]Costanza E,Maria BS,Tiziana S,et al.Rescue of imparted angiogene-sis in spontaneously hypertensive rats by intramuscular human tissuekallikrein gene transfer[J].Hypertension,2001,38(1):136.

[5]于忠和,李继成,钱桂生.肾上腺髓质素的研究进展[J].国外医学.生理病理科学与临床分册,2000,20(5):380.

[6]Chao JL,Kazuo K,Zhang JJ,et al.Human adrenomedulline gene deliv-ery protects against cardiovascular remodeling and renal injury[J].Pep-tides,2001,22(11):1731.

[7]Lin KF,Chao J,Chao L.Atrial natriuretu peptide gene delivery reducesstroke-induced mortality rate in Dahl salt-sensitive rats[J].Hyperten-sion,1999,33(1pt2):219.

[8]李涛,梁红雁,卢果,等.皮下移植心钠素基因表达细胞胶囊对高血压大鼠的降血压效应[J].中华医学杂志,2002,82(16):1086.

[9]汪培华,赵春霞,林立,等.内皮型一氧化氮合酶基因对果糖诱导高血压大鼠的降压效应[J].中华心血管病杂志,2003,31(4):289.

[10]Marie J,Karel H,Jan B,et al.Association of the Glu298 Asp polymor-phism in the endothelial nitric oxide synthase gene with essential hyper-tension resistant to conventional therapy[J].Biochem Biophys ResCommun,2001,284(2):426.

[11]Alexander MY,Brosnan MJ,Carlene AH,et al.Gene transfer of en-dothelial nitrix oxide synthase improves nitric oxide-dependent endothe-lial function in a hypertensive rat model[J].Cardiovasc Res,1999,43(3):789.

[12]Alexander MY,Brosnan MJ,Carlene AH,et al.Gene transfer of en-dothelial nitrix oxide synthase but not Cu/Zn superoxide dismutase re-stores nitric oxide availability in the SHRSP[J].Cardiovasc Res,2002,47(3):609.

[13]江德文,吴可贵,高丽真,等.基因治疗原发性高血压的新途径:内皮型一氧化氮合成酶CDNA腺病毒载体在人胚肾293细胞的表达[J].中国临床康复,2003,7(30):4062.

[14]Birgitta K,Dogmara M,Tang XP,et al.Attenuation of hypertensionand heart hypertrophy adeno-associated virus delivering angiotensinogenantisense[J].Hypertension,2001,37(2pt2):376.

[15]Phyills PY,Wang HW,Michael JK,et al.Attenuation of hypertensionby systemic delivery of retrovial vector containing typeⅠangiontensionⅡreceptor antisense cDNA[J].Methods,2000,22,(3):11.

[16]Philps MI,Galli SM,Jawaharl M.The potential role of antisenseoligodeoxynucleotide therapy for cardiovasular disease[J].Drugs,2000,60(2):239.

[17]Wang H,Reaves PY,Gardon ML,et al.AngiotensionⅠ-converting en-zyme antisense gene therapy cause permanent antihypentensive effects inthe SHR[J].Hypertension,2000,35(1pt2):202.

[18]Niu TH,Chen X,Xu XP.Angiotension converting enzyme gene inser-tion/deletion polymorphism and cardiovascular disease[J].Drugs,2002,62(7):987.